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BRIEF DEFINITIVE REPORT
 Members of the Wnt family of secreted glyco-
proteins function as critical regulators of cell 
fate and cell growth during development. To 
date, 20 diff erent mammalian Wnt genes have 
been identifi ed and categorized based upon 
their ability to activate diff erent signaling path-
ways in the cell and to transform cells in cul-
ture ( 1 – 4 ). The canonical-signaling mammalian 
Wnts (typifi ed by Wnt1, 3a, and 8) bind to a 
cell surface receptor complex composed of the 
appropriate member of the Frizzled (Frz) fam-
ily of seven transmembrane proteins and the 
low-density lipoprotein receptor-related LRP-5 
or -6 ( 5 – 7 ). This binding activates the cytosolic 
phosphoprotein Disheveled and inhibits the 
function of a degradation complex containing 
the adenomatous polyposis coli protein Axin 
and glycogen synthase kinase 3. Inhibition of 
glycogen synthase kinase 3, which phosphory-
lates   -catenin and targets it for ubiquitin-
mediated proteosomal degradation, leads to the 
accumulation of   -catenin and transport into 
the nucleus by Pygopus and legless/BCL-9. 
Nuclear   -catenin complexes with the tran-
scription factors LEF/TCF to transform these 
proteins from transcriptional repressors into 
activators ( 8 ). Thus, canonical Wnt signaling 
increases   -catenin stability and up-regulates 
the expression of LEF/TCF-induced genes 
whose products regulate cell proliferation and 
diff erentiation. Inappropriate activation of hu-
man canonical Wnt signaling has often been 
associated with cell transformation in vitro and 
with several types of human cancer ( 4, 9 ). 
 In contrast, noncanonical Wnt signaling in-
volves recognition of extracellular Wnt ligands 
by a cognate Frz – LRP receptor complex, het-
erotrimeric G protein activation of phospholi-
pase C and turnover of phospholipid membranes 
in the endoplasmic reticulum, and the release 
of intracellular calcium ions. In some contexts, 
increased intracellular Ca 2+ activates protein 
kinase C (PKC), as well as other calcium-sen-
sitive enzymes, such as calmodulin-dependent 
kinase II (CamKII), calcineurin, and the calci-
neurin-dependent, NFAT transcription factor 
( 10 ). Although transduction of cells with non-
canonical WNT ligands such as Wnt5a only 
weakly transforms cells in vitro ( 4 ), activation 
of the Wnt – Ca 2+ pathway by Wnt5a has been 
found to up-regulate the proliferation of mes-
enchymal cells during mouse axial formation 
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 The Wnt –  -catenin signaling pathway has been shown to govern T cell development by 
regulating the growth and survival of progenitor T cells and immature thymocytes. We 
explore the role of noncanonical, Wnt – Ca 2+ signaling in fetal T cell development by analyzing 
mice defi cient for Wnt5a. Our fi ndings reveal that Wnt5a produced in the thymic 
stromal epithelium does not alter the development of progenitor thymocytes, but regulates 
the survival of    lineage thymocytes. Loss of Wnt5a down-regulates Bax expression, 
promotes Bcl-2 expression, and inhibits apoptosis of CD4 + CD8 + thymocytes, whereas 
exogenous Wnt5a increases apoptosis of fetal thymocytes in culture. Furthermore, Wnt5a 
overexpression increases apoptosis in T cells in vitro and increases protein kinase C (PKC) 
and calmodulin-dependent kinase II (CamKII) activity while inhibiting   -catenin expression 
and activity. Conversely, Wnt5a defi ciency results in the inhibition of PKC activation, 
decreased CamKII activity, and elevation of   -catenin amounts in thymocytes. These results 
indicate that Wnt5a induction of the noncanonical Wnt – Ca 2+ pathway alters canonical 
Wnt signaling and is critical for normal T cell development. 
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normal mice ( 27 ), and soluble Frz receptors can block thy-
mocyte development in FTOCs at the DN – DP transition 
( 23 ). In contrast, where examined,    T cells appear largely 
unaff ected by the manipulations of WNT signaling ( 21 ). 
Collectively, the data suggest that canonical WNT signaling 
is primarily critical in regulating proliferation and survival of 
   T cell lineage at the DN – DP stages. Although the rescue 
of thymopoiesis in TCF1-defi cient mice by expression of 
TCF1 transgenes has been found to require the   -catenin –
 interacting region of TCF1 ( 28 ), mice defi cient in   -catenin 
display unexpectedly limited alterations in T cell development 
( 29 ), raising the question as to the extent to which TCF1 func-
tion is controlled by   -catenin in thymocytes. Regardless of the 
precise mechanism, the importance of Wnt –  -catenin signaling 
in thymopoiesis is widely accepted. However, nothing is known 
about the function of noncanonical Wnt – Ca 2+ signaling in 
thymocyte development. 
 Several lines of evidence indicate that Wnt5a is an impor-
tant regulator of cell growth in hematopoietic tissue, and its 
expression in the thymus raises the possibility for the existence 
and limb development ( 11 ), regulate convergent extension 
movements of  Xenopus laevis and zebrafi sh embryos ( 12 – 15 ), 
and to govern cell planar polarity in vertebrates and  Drosophila 
melanogaster ( 16 ). Furthermore, activation of the Wnt – Ca 2+ 
signaling pathway by Wnt5a has been demonstrated to in-
hibit   -catenin stabilization and antagonize the canonical 
Wnt –  -catenin signaling pathway in vertebrate axis forma-
tion and limb development in zebrafi sh and mice, respec-
tively ( 17, 18 ). More recently, treatment of HEK293 cells 
with WNT5a ligand was found to induce   -catenin stabiliza-
tion and up-regulate TCF/LEF promoter activity, as well as 
to inhibit canonical Wnt signaling without altering   -catenin 
levels, depending on the WNT receptor expressed on the cell 
( 19 ). Therefore, Wnt5a is likely to have multiple, and some-
times opposing, roles in cell growth and development, de-
pending on which signaling pathways are induced or suppressed 
in the cell. 
 Canonical Wnt signaling has been proposed to play im-
portant roles in the development of mammalian T cells ( 20 ). 
T cells develop primarily in the thymus, where precursor cells 
undergo distinct proliferation and diff erentiation steps that are 
tightly regulated by the thymic stromal microenvironment. 
Precursor T cells lacking CD4 and CD8 undergo TCR   -
chain rearrangement and begin to proliferate and express CD4 
and CD8 coreceptors on the cell surface. These immature 
CD4 + CD8 + double-positive (DP) cells will, in turn, gener-
ate mature single-positive (SP), self-MHC – restricted CD4 + 
or CD8 + T cells, which then leave the thymus and enter the 
peripheral circulation. Several diff erent molecular pathways, 
including Wnt signaling, coordinate the development of T 
cells in the thymus ( 21 ). Two major T cell types expressing 
diff erent TCRs are generated in the thymus: conventional 
   TCR + T cells of adaptive immunity and    TCR + T cells 
that exhibit traits of both adaptive and innate immunity. T cells 
of the    lineage undergo a well-defi ned developmental pro-
gression, with each stage distinguished by the cell surface 
antigens CD4 and CD8. Double-negative (DN) CD4    CD8    
precursor cells, consisting of four subsets (DN1 – DN4) de-
fi ned by distinct CD25 and CD44 expression patterns, dif-
ferentiate into immature CD4 + CD8 + DP thymocytes if they 
express functional TCR. A minor subset of DP cells can then 
be selected based on their TCR specifi city and diff erentiate 
into either helper CD4 + CD8    or cytotoxic CD4    CD8 + ma-
ture SP thymocytes. Developmental steps in the    lineage 
are not well characterized, but these cells arise early from the 
DN stage, and most do not express CD4 or CD8. 
 Numerous Wnt genes are expressed in thymocytes or in 
thymic epithelial stromal cells ( 22 ), and overexpression of 
Wnt genes can increase thymocyte proliferation in vitro ( 23 ). 
Mice defi cient in LEF1/TCF1 are depleted of    lineage 
thymocytes, and overexpression of extracellular Wnt inhibi-
tors can partially block    T cell development in fetal thymic 
organ cultures (FTOCs) ( 24 – 26 ), suggesting that canonical 
Wnt signaling is essential for normal thymocyte develop-
ment. In addition, deletion of Wnt1 and Wnt4 in mice re-
duces the number of thymocytes by   50% compared with 
Figure 1. Expression pattern of Wnt5a in thymus and thymocytes. 
(A) RT-PCR analysis of Wnt5a expression in fetal and adult thymocytes or 
thymus. PCR of total RNA isolated from adult thymocytes in the absence 
of RT served as the negative control. (B) RT-PCR analysis of Wnt5a ex-
pression in stroma of E18 WT mice. PCR of total RNA isolated from the 
stroma in the absence of RT served as the negative control. (C) RT-PCR 
analysis of Wnt5a expression in FACS-purifi ed DN1 (CD44+CD25) thymo-
cytes, DN2 (CD44+CD25+) thymocytes, SP CD4+ and CD8+ thymocytes, 
BM-derived pro–/pre–B cells (B220+CD43 and B220+CD43+ cells), and 
HTY cells overexpressing Wnt5a and thymus as positive controls. Amplifi -
cation of c-kit receptor, transcription factor GATA-3, and the housekeeping 
gene HPRT served as controls for sorted cell populations
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isolated from perinatal (embryonic day [E] 18) and adult mice 
by RT-PCR, but was not detected in thymocytes isolated 
from E18 or adult mice ( Fig. 1 A ). However, Wnt5a ex-
pression was observed in stromal cells derived from newborn 
mice ( Fig. 1 B ). Defi ned adult thymocyte subsets were puri-
fi ed from C57BL/6 mice using fl uorescence-activated cell 
sorting. RT-PCR analysis of Wnt5a expression was per-
formed in parallel with control RT-PCR assays for c-Kit 
(precursor-restricted), Gata-3 (T cell lineage-specifi c), or Hprt 
(positive control) expression to confi rm the identity of the 
sorted T cell populations ( 30, 31 ). In some samples, CD4 and 
CD8 cells isolated from C57BL/6 mice were stimulated for 
3 d with immobilized anti-CD3 (5   g/ml) and anti-CD28 
(0.1   g/ml) to activate T cells. The results ( Fig. 1 C ) indicate 
that Wnt5a is expressed at barely detectable levels in mouse 
SP thymocytes, but Wnt5a expression is not detected in DN1 
(CD44 + CD25    ) and DN2 (CD44 + CD25 + ) precursor subsets. 
These results indicate that Wnt5a is produced primarily by the 
thymic epithelium during T cell development. 
 Mice lacking Wnt5a die at birth and display severe caudal 
defects and reduced morphogenesis of all tissues that out-
grow from the main body axis ( 11 ). Staining of thymocytes 
harvested from E17.5 Wnt5a   /   embryos (C57BL/6 back-
ground) revealed no diff erence in the percentage of CD25 + , 
CD44 + , and CD25 + /CD44 + cells, indicating normal DN pre-
cursor diff erentiation (unpublished data). To explore a role 
for Wnt5a signaling in T cell development, FTOCs were 
of noncanonical WNT signaling during T cell development. 
Addition of Wnt5a to cultured cells stimulates lymphoid and 
myeloid progenitor cells, and intraperitoneal injection of 
Wnt5a in mice was found to augment the repopulating capacity 
of transplanted human hematopoietic stem cells ( 30 ). In addition, 
we have shown that Wnt5a signals through the noncanonical 
Wnt – Ca 2+ pathway to inhibit B cell proliferation and sponta-
neous B cell tumorigenesis in mice ( 31 ). To determine if Wnt5a 
also plays a role in T cell development, we examined T cell 
development and apoptosis in fetal mice defi cient for Wnt5a 
and in FTOCs derived from these mice. Our results reveal that 
noncanonical Wnt – Ca 2+ signaling induced by Wnt5a originat-
ing in the thymic epithelium operates in the thymus to govern 
survival of DP and mature SP thymocytes in a manner an-
tagonistic to canonical WNT signaling. 
 RESULTS AND DISCUSSION 
 Previous experiments using RT-PCR assays have documented 
the expression of multiple Wnt genes in mouse thymic epi-
thelium, including Wnt1, 4, 5b, 7a, 7b, 10a, and 10b ( 21, 24 ). 
Less is known about the expression of noncanonical Wnt 
genes in mouse thymus, although expression of WNT5a 
has been detected previously in human thymic stroma ( 21 ). 
To determine if Wnt5a is expressed in mouse thymocytes 
or stromal epithelial cells, total RNA was extracted from 
C57BL/6 mouse thymi or from epithelial cells cultured from 
mouse thymi. Wnt5a expression was readily detected in thymi 
Figure 2. Differentiation and hyperproliferation of thymocytes in Wnt5a/ mice. (A) Representative result of fl ow cytometry analysis of CD4 
and CD8 antibody-stained Wnt5a+ /+ and Wnt5a / FTOC cells. (B) Mean total numbers of CD4+ or CD8+ cells in FTOCs derived from four embryos for 
each genotype. (C) Representative fl ow cytometry analysis of TCR- antibody-stained Wnt5a+ /+ and Wnt5a / FTOC cells, and mean percentage of TCR- 
SP cells in FTOCs derived from four embryos given for each genotype. (D) [3H]thymidine uptake assay performed on cultured CD4+ cells, sorted from 
Wnt5a+ /+ and Wnt5a / FTOCs in the presence or absence of anti-CD3 and -CD28 antibodies. All experiments presented in this fi gure were performed 
using three samples, and were repeated three times with similar qualitative results. Error bars display the SD. P < 0.05.
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molecules. The results indicate a reduced frequency of DN 
thymocytes in Wnt5a   /   thymi, but similar percentages and 
numbers of DP cells produced in Wnt5a   /   and WT control 
fetal thymi ( Fig. 2 A ). However, the frequencies and  numbers 
generated from E17.5 embryos harvested from intercrosses 
of Wnt5a-heterozygous mice. Analysis of thymocyte popula-
tions was performed by staining of the cells after 4 d in cul-
ture using antibodies to a panel of lineage-specifi c cell surface 
Figure 3. Absence of Wnt5a increases the survival of thymocytes. (A) Representative profi les of TUNEL+ frequencies in DP thymocytes isolated 
from Wnt5a+ /+ or Wnt5a / FTOCs (E17.5) on day 5 of culture. Bars represent the percentage of TUNEL+ cells. (B) Representative Western blot on ex vivo 
E18.5 thymocytes with primary antibodies against Bax, Bcl-XL, or tubulin (the loading control). (C) Real-time PCR on total RNA extracted from E18.5 
Wnt5a+ /+ or Wnt5a / thymocytes. Bax levels were normalized to Gapdh as an internal control. Results are averaged from three samples per genotype. 
(D) Bcl2 intercellular staining of thymocyte subsets from E18.5 Wnt5a+ /+ or Wnt5a / thymi. All experiments in A–D were performed three times with 
similar results. Error bars display the SD. P < 0.05. (E) Growth of cells after treatment with Wnt5a in E15.4 (left) or E16.5 (right) FTOCs. Values from eight 
pooled lobes per sample. This experiment was independently repeated with similar results. (F) Loss of DP and SP cells after Wnt5a treatment. Representa-
tive FACS data of three independent experiments is shown. (G) Decreased survival of thymocytes after treatment of FTOCs with Wnt5a. Survival was 
assayed by FACS analysis on day 4 in culture by counting the numbers of cells not staining for 7-amino-actinomycin-D or Annexin V. The value for 
untreated cells in each population was set at 100. This experiment was repeated once, with similar qualitative results.
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performed to compare the levels of Bax mRNA. Compared 
with WT DP cells, Bax RNA amounts were reduced by 80% 
in the Wnt5a   /   DP cells ( Fig. 3 C ), whereas Bcl-X L levels 
were unperturbed (not depicted). Furthermore, intracellu-
lar staining for the prosurvival molecule Bcl-2 showed up-
regulation of Bcl2 levels, most notably in Wnt5a   /   CD8 + SP 
thymocytes. These results indicate diminished apoptosis in 
thymocytes developing in the absence of Wnt5a, and sug-
gest that Wnt5a normally promotes apoptosis in immature 
and mature T cells by controlling the relative amounts of 
proapoptotic Bax versus antiapoptotic Bcl2. To confi rm that 
Wnt5a regulates the survival of thymocytes, we generated 
FTOCs from WT mice and added exogenous Wnt5a ligand 
to the culture media. Addition of exogenous Wnt5a inhib-
ited the growth of cells in FTOCs prepared from E15.5 or 
E16.5 WT embryos ( Fig. 3 E, left and right). FTOCs treated 
with exogenous Wnt5a ligand had less DP and SP cells pres-
ent on day 4 of culture ( Fig. 3 F ), and staining of FTOCs 
with Annexin V and 7-amino-actinomycin-D revealed that 
addition of exogenous Wnt5a ligand promoted the apoptosis 
of immature and mature SP thymocytes ( Fig. 3 G ). In keep-
ing with the fi ndings of reduced Bax mRNA in Wnt5a   /   
FTOCs, the addition of exogenous Wnt5a to WT FTOCs 
moderately increased Bax mRNA levels by 20% (unpub-
lished data). 
 The results of the FTOC experiments indicate that Wnt5a 
regulates survival of thymocytes. To demonstrate that the ef-
fects were attributable to direct actions of Wnt5a on thymo-
cytes and to examine activation of the noncanonical Wnt 
of CD4 + or CD8 + SP thymocytes were elevated twofold in 
Wnt5a   /   FTOCs ( Fig. 2, A and B ). In addition, there was 
an increase both in the percentage and numbers ( Fig. 2 C ) of 
thymocytes expressing high levels of TCR-  receptors, which 
is consistent with an increase in the development, maintenance, 
and/or proliferation of mature SP cells in the absence of  Wnt5a. 
No signifi cant diff erence in the composition and cellularity 
of    T cell lineage was observed in the absence of Wnt5a 
(unpublished data). 
 Consistent with the possibility of enhanced growth or sur-
vival of    T cell lineage, Wnt5a   /   SP CD4 + thymocytes 
expanded signifi cantly better than WT CD4 + thymocytes 
when activated by CD3 and CD28 ( Fig. 2 D ). A previous 
study showed that canonical Wnt signaling promotes DP cell 
survival by inducing the antiapoptotic BCL-X L protein ( 27 ). 
To determine if Wnt5a regulates cell survival, DP cells from 
day 5 FTOCs were assayed for apoptosis by TUNEL staining 
( Fig. 3 A ). Nearly 60% of the WT DP cells were undergoing 
apoptosis at this time, whereas  < 40% of Wnt5a   /   DP cells 
were apoptotic, suggesting that Wnt5a normally promotes 
DP cell apoptosis. Western blot analysis of pro- or antiapop-
totic proteins in DP cells suggested a reduction in proapop-
totic Bax levels in the absence of Wnt5a, whereas Bcl-X L 
levels were unchanged ( Fig. 3 B ). In addition, no diff erences 
were detected in the levels of other proapoptotic molecules 
in these cells, such as the p53-related Puma or Noxa (unpub-
lished data). To confi rm the reduction in Bax levels in cells 
lacking Wnt5a, and to determine if this reduction was occur-
ring at the transcription level, quantitative real-time PCR was 
Figure 4. Wnt5a suppresses cell proliferation and promotes apoptosis in a Wnt5a-transduced mouse thymoma cell line. (A) Western blot with 
primary antibody against mouse Wnt5a on Wnt5a-infected NFC cell extract to verify Wnt5a expression after transduction with the Wnt5a retroviral vector. 
(B) Proliferation curve of Wnt5a-infected or empty vector–infected (e.v.) NFC cells. Points represent the mean of the samples. Error bars display the SD. 
(C) TUNEL assay on Wnt5a-infected or control e.v. NFC cells 24 h after serum starvation. Percentage of TUNEL+ cells is given. (D) Western blot on 
protein extracts of Wnt5a-infected or e.v. NFC cells using primary antibodies against Bax or -tubulin. (E) Real-time PCR on total RNA extracted from 
Wnt5a-infected NFC cells. Bax levels were normalized to Gapdh as an internal control. Error bar displays the SD. P < 0.05, except CD4+ staining for Bcl2. 
All experiments were repeated twice, with similar qualitative results.
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dent on exogenous   -catenin activity. Expression of Wnt5a 
signifi cantly inhibited activation of the promoter after co-
transfection with   -catenin, confi rming that Wnt5a inhibits 
the activity of   -catenin/TCF1 in T cells ( Fig. 5 E ), 
 The outcome of Wnt5a signaling in hematopoietic cells 
appears to depend on the cell context. We have previously 
reported that Wnt5a functions in B cells to inhibit cell prolif-
eration and suppress lymphomagenesis. However, Wnt5a 
clearly regulates apoptosis in T cells, but not in B cells. And 
although Wnt5a activates the Wnt – Ca 2+ pathway in both T 
and B cells, Wnt5a inhibition of   -catenin was only observed 
in thymocytes. Lastly, Wnt5a expression is readily detected in 
B cell precursors, whereas the majority of Wnt5a present in 
the thymus appears to originate in the stroma. To confi rm 
that Wnt5a produced in the stromal microenvironment could 
rescue the phenotype of Wnt5a   /   thymocytes, we per-
formed adoptive transplants in Rag1   /   mice using fetal liver 
cells harvested from E15.5 WT or Wnt5a   /   embryos. No 
diff erence was observed in the percentage of DN, DP, or SP 
signaling pathway in T cells, we ectopically expressed Wnt5a 
( 28 ) in NFC cells ( 31 ), a CD4 + CD8 +    lineage T cell line 
that lacks endogenous Wnt5a expression ( Fig. 4 A ). NFC-
WNT5a cells expanded signifi cantly slower in culture than 
NFC cells transduced with control empty vector ( Fig. 4 B ). 
Furthermore, the level of apoptosis after serum withdrawal 
was elevated in cells expressing Wnt5a relative to the levels of 
apoptosis in control NFC cells ( Fig. 4 C ). In keeping with the 
results observed in the FTOC experiments, transduction of 
Wnt5a up-regulated Bax protein levels ( Fig. 4 D ) concomi-
tant with a fourfold increase in Bax gene expression ( Fig. 4 E ), 
confi rming that Wnt5a is proapoptotic in thymocytes. 
 To examine if Wnt5a signals via the noncanonical or 
 canonical Wnt pathway in thymocytes, Wnt – Ca 2+ signaling 
and   -catenin stabilization were analyzed in Wnt5a-trans-
duced NFC cells. The levels of activated PKC ( Fig. 5 A ) and 
CamKII activity ( Fig. 5 B ) were clearly elevated in Wnt5a-
expressing cells. Furthermore,   -catenin levels were not 
stimulated, but rather were consistently reduced by Wnt5a 
expression ( Fig. 5 A ). These data indicate that Wnt5a is sig-
naling through the noncanonical pathway in thymocytes. To 
confi rm these results in vivo, total protein was extracted from 
E17.5 thymocytes isolated from WT and Wnt5a   /   litter-
mates, and relative amounts of proteins in the Wnt signaling 
pathway were assayed. Consistent with the in vitro results, 
the amount of activated PKC was clearly reduced in Wnt5a   /   
thymocytes relative to controls ( Fig. 5 C ). In addition, 
  -catenin levels were signifi cantly elevated in Wnt5a   /   
thymocytes. In addition, CamKII activity was decreased in 
thymocytes isolated from thymus of Wnt5a   /   embryos 
(E18). These data indicate that Wnt5a activates the Wnt –
 Ca 2+ pathway in developing thymocytes in vivo, and may 
inhibit canonical Wnt signaling. Because   -catenin is nor-
mally expressed at the highest level in DN thymocytes and 
Wnt5a   /   mice show a marginal reduction in DN thymo-
cytes, the observed increase in   -catenin amounts cannot be 
attributed to altered thymic subset composition in Wnt5a   /   
thymus. As   -catenin/TCF1 signaling has been shown to 
ensure the survival of DP thymocytes ( 27 ), Wnt5a may 
normally contribute to the regulation of cell survival by 
countering the antiapoptotic function of   -catenin/TCF1. 
However, the consequence of this antagonism does not ap-
pear to involve the TCF1 target Bcl-X L , as Bcl-X L levels 
appear unchanged when Wnt5a is not present ( Fig. 3 B ). 
Instead, Wnt5a may promote apoptosis by up-regulating Bax 
gene expression. To determine if Wnt5a can induce altera-
tions in   -catenin activity, NFC cells that were mock trans-
fected or transfected with a Wnt5a expression vector were 
cotransfected with a   -catenin expression vector and TOP-
FLASH, which is a reporter plasmid – bearing luciferase gene 
under transcriptional control of a   -catenin/TCF1 – responsive 
promoter. A plasmid encoding  Renilla luciferase was also co-
transfected as a control for transfection effi  ciency. Expres sion 
of the TOPLASH reporter was not detectible in the ab-
sence of cotransfected   -catenin in these cells. Thus, the 
  -catenin/TCF1 – responsive promoter is exclusively depen-
Figure 5. Wnt5a signals through the noncanonical Wnt pathway 
in thymocytes. Western blot on Wnt5a-infected or empty vector–
infected (e.v.) NFC cell protein extracts (A) and on protein extracts of Wnt5a+ /+ 
or Wnt5a / E18.5 thymocytes (D) with primary antibodies against 
phosphorylated PKC, -catenin, or -tubulin. (B) CamKII activity assays 
performed on Wnt5a-infected or e.v. NFC cells. (C) Representative Western 
blot displaying inhibition of activated PKC and -catenin levels in fetal 
thymocytes. (D) CamKII assays performed on E18 fetal thymocytes reveals 
reduced CamKII activity in Wnt5a/ cells. All experiments in A–D were 
performed three times with similar results. Error bars represent the SD. 
P < 0.05. (E) Addition of Wnt5a inhibits -catenin activation of TOPFLASH 
reporter in NFC cells. RLU, relative luciferase activity. Results are the mean 
of three independent transfections. This assay was repeated twice, with 
similar qualitative results. Error bars represent the SD. P < 0.05.
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performed by plating 1  × 10 5 cells into the wells of 96-well plates with 
200   l of RPMI 1640 media supplemented with 20% fetal calf serum in the 
presence or absence of anti-CD3 and -CD28 antibody-coated beads. After 
48 h in culture, the cells were pulsed with [ 3 H]thymidine (1   Ci per well) 
for 18 h before harvest. Incorporated radioactivity was measured using a liq-
uid scintillation counter (Perkin Elmer Wallace, Inc). Apoptosis of thymo-
cytes was assayed using TUNEL (Guava Technologies, Inc.) and FACS 
analysis (BD Biosciences), and intracellular BCL-2 staining was performed 
using anti-Bcl2 mAb (BD Biosciences), according to the manufacturer ’ s 
protocol. Recombinant mouse Wnt5a ligand (R & D Systems) was used at 400 
or 600 ng/ml in the FTOC cultures in the presence of 2 ng/ml of rIL-7 
(R & D Systems). 
 Transduction of Wnt5a in T cells.  NFC cells were maintained in com-
plete RPMI media with 10% fetal calf serum. Recombinant retrovirus 
carrying mouse Wnt5a cDNA was previously described ( 29 ). Retroviral-
transduced cells expressing GFP were plated in triplicate at 2  × 10 5 cells 
per 10-cm plate, and plates were harvested and counted every 12 h to 
measure the rates of cell proliferation. Transfections of NFC cell were 
performed using an electroporator (Bio-Rad Laboratories), and a  Renilla 
luciferase plasmid (pRL-TK) was added in equal amounts to all transfec-
tions. Luciferase data from each sample was fi rst normalized to the  Renilla 
luciferase activity to account for diff erences in transfection effi  ciencies for 
each sample. 
 Western blot analysis.  Cells and tissue were lysed with 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% SDS, and protease inhibitor in PBS. Proteins 
were separated on a 10% polyacrylamide gel and transferred to nitrocellulose 
membrane. Immunoblots were probed with primary antibodies to Wnt5a 
(R & D Systems), Bax (BD Biosciences), Bcl-X L (Cell Signaling Technology), 
CamKII, CyclinD1 or Cyclin D3 (Santa Cruz Biotechnology, Inc.), phos-
phorylated PKC-pan (Cell Signaling Technology), or   -catenin-Exon 3 
(Calbiochem), and subsequently stained with anti – IgG-HRP antibodies and 
visualized using ECL (GE Healthcare). An antibody against   -tubulin was 
used as a loading control (Sigma-Aldrich). 
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